Transcription of Major R&D Pipeline - eisai.com
{{id}} {{{paragraph}}}
Example: barber
Major R&D Pipeline - eisai.com
Reference Data [R&D Pipeline ] 19 November 1, 2018 / Eisai Co., Ltd. 13. Major R&D Pipeline In-House R&D Pipeline List Product Name / Development Code Additional Indication, etc.** Development Stage** Therapeutic Area** Approved Lenvima (Hepatocellular carcinoma: HCC) Al (US/EU/CN/AS) approved Oncology Fycompa (Pediatric epilepsy) AI (US) approved Neurology Movicol (Chronic constipation)* (JP) approved GI Submitted / Preparing for Submission Halaven (Breast cancer) (CN) submitted Oncology Fycompa (Adjunctive therapy for partial-onset seizures) (CN) submitted Neurology ME2125 (Parkinson s disease) (JP) submitted Neurology Clinical Trial Stage E2006 (Insomnia disorder) (JP/US/EU) PIII Neurology E2609 (Early Alzheimer s disease) (JP/US/EU/CN) PIII Neurology BIIB037 (Early Alzheimer s disease) (JP/US/EU)
Reference Data [R&D Pipeline] 17 August 1, 2018 / Eisai Co., Ltd. 11. Major R&D Pipeline In-House R&D Pipeline List Product Name / Development Code
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: